SALT LAKE CITY--(BUSINESS WIRE)--RemedyMD Inc. and GulfStream Bioinformatics Corp., leading providers of clinical and translational research solutions, today announced a partnership to provide researchers with a combination of applications, data and tools that enable unprecedented advances in translational research. RemedyMD is incorporating GulfStream’s 75 disease models into the Investigate™ research software suite. As part of the partnership, RemedyMD is integrating GulfStream’s biospecimen management system, BIGR®, into its Investigate suite of applications.
